| Jul 10 |
Centers for Medicare and Medicaid Propose New Reimbursement for EXPAREL in All Outpatient Surgical Environments Beginning January 1, 2025
|
| Jul 8 |
Top 5 Health Care Stocks That May Explode In July
|
| Jul 3 |
Pacira downgraded at Barclays following generic Exparel approval
|
| Jul 2 |
Pacira down 25% as FDA approves generic version of Exparel
|
| Jun 20 |
Declining Stock and Decent Financials: Is The Market Wrong About Pacira BioSciences, Inc. (NASDAQ:PCRX)?
|
| Jun 14 |
Insider Sale: Chief Medical Officer Jonathan Slonin Sells Shares of Pacira BioSciences Inc (PCRX)
|
| May 30 |
Pacira BioSciences to Participate in Fireside Chat at the 2024 Jefferies Global Healthcare Conference
|
